T0	Participants 115 145	stem cell transplant patients.
T1	Participants 287 350	117 patients who had undergone stem cell transplantation (SCT).
T2	Participants 720 755	subgroup of allogeneic SCT patients
T3	Participants 893 935	autologous SCT patients with breast cancer
T4	Participants 1203 1215	SCT patients